Skip to main content
. 2023 Sep 8;2023(9):CD001888. doi: 10.1002/14651858.CD001888.pub5

22. Overview of results: Orthopaedic (knee).

Outcome Total
[95% CI]
Subgroup: blood salvage (collection time) Subgroup: transfusion threshold
Intraoperative Postoperative Both No transfusion threshold Liberal threshold (Hb > 80 g/L) Restrictive threshold (Hb80 g/L)
Risk of transfusion RR 0.49 [0.37, 0.66]
21 RCTs, N = 2214
⨁◯◯◯
  RR 0.45 [0.32, 0.63]
20 RCTs, N = 1939
⨁◯◯◯
RR 0.82 [0.67, 1.01] *
2 RCTs, N = 275
⨁⨁◯◯
RR 0.16 [0.02, 1.32]
3 RCTs, N = 238
⨁◯◯◯
RR 0.44 [0.29, 0.64]
12 RCTs, N = 1142
⨁◯◯◯
RR 0.81 [0.65, 1.01] *
6 RCTS, N = 834
⨁⨁◯◯
Volume transfused (PPR) MD ‐0.87 [‐1.09, ‐0.64]
5 RCTs, N = 563
⨁⨁◯◯
  MD ‐0.84 [‐1.13, ‐0.55]
5 RCTs, N = 428
⨁⨁◯◯
MD ‐0.93 [‐1.29, ‐0.57]
1 RCTs, N = 135
⨁⨁◯◯
  MD ‐0.87 [‐1.09, ‐0.64]
5 RCTS, N = 563
⨁⨁◯◯
 
Volume transfused (PPT) MD ‐0.54 [‐0.90, ‐0.19]
3 RCTs, N = 221
⨁◯◯◯
  MD ‐0.37 [‐0.81, 0.07]
RCTs, N = 130
⨁◯◯◯
MD ‐0.89 [‐1.16, ‐0.62]
1 RCT, N = 91
⨁⨁◯◯
  MD ‐0.54 [‐0.90, ‐0.19]
3 RCTs, N = 221
⨁◯◯◯
 
All‐cause mortality              
Blood loss MD ‐79.01 [‐170.27, 12.24]
9 RCTs, N = 629
⨁⨁◯◯
  MD ‐79.01 [‐170.27, 12.24]
9 RCTs, N = 629
⨁⨁◯◯
  MD 5.00 [‐219.16, 229.16]
1 RCT, N = 70
⨁◯◯◯
MD ‐56.24 [‐175.85, 63.37]
6 RCTs, N = 344
⨁⨁⨁◯
MD ‐200.89 [‐384.06, ‐17.72]
2 RCTs, N = 215
⨁⨁⨁◯
Re‐operation RD 0.00 [‐0.02, 0.02]
1 RCT, N = 178
⨁◯◯◯
  RD 0.00 [‐0.02, 0.02]
1 RCT, N = 178
⨁◯◯◯
      RD 0.00 [‐0.02, 0.02]
1 RCT, N = 178
⨁◯◯◯
Infection POR 0.74 [0.28, 1.94]
5 RCTS, N = 730
⨁◯◯◯
  POR 0.86 [0.29, 2.52]
5 RCTS, N = 595
⨁◯◯◯
POR 0.43 [0.05, 3.57]
1 RCT, N = 135
⨁◯◯◯
POR 0.35 [0.05, 2.61]
1 RCT, N = 70
⨁◯◯◯
POR 0.70 [0.17, 2.77]
2RCTs, N = 360
⨁◯◯◯
POR 1.52 [0.25, 9.08]
2 RCTs, N = 300
⨁◯◯◯
Wound complication POR 1.42 [0.61, 3.31]
6 RCTs, N = 734
⨁◯◯◯
  POR 1.42 [0.61, 3.31]
6 RCTs, N = 734
⨁◯◯◯
    POR 1.15 [0.41, 3.19]
4 RCTs, N = 356
⨁◯◯◯
POR 2.27 [0.50, 10.24]
2 RCTs, N = 378
⨁◯◯◯
PJI RD 0.00 [‐0.01, 0.01]
4 RCTs, N = 663
⨁◯◯◯
  RD 0.00 [‐0.01, 0.01]
4 RCTs, N = 528
⨁◯◯◯
RD 0.00 [‐0.03, 0.03]
1 RCT, N = 135
⨁◯◯◯
  RD 0.00 [‐0.03, 0.03]
1 RCT, N = 248
⨁◯◯◯
RD 0.00 [‐0.02, 0.02]
3 RCTs, N = 415
⨁◯◯◯
VTE/thrombosis              
DVT POR 1.29 [0.56, 2.95]
9 RCTs, N = 793
⨁◯◯◯
  POR 1.29 [0.56, 2.95]
9 RCTs, N = 793
⨁◯◯◯
  Not estimable (zero cases)
1 RCT, N = 70
⨁⨁◯◯
POR 1.50 [0.62, 3.65]
6 RCTs, N = 462
⨁◯◯◯
POR 0.48 [0.05, 4.64]
2 RCTs, N = 293
⨁◯◯◯
PE POR 0.51 [0.10, 2.52]
6 RCTs, N = 574
⨁◯◯◯
  POR 0.51 [0.10, 2.52]
6 RCTs, N = 574
⨁◯◯◯
    POR 0.30 [0.05, 1.73]
5 RCTs, N = 459
⨁◯◯◯
POR 7.02 [0.14, 354.40]
1 RCT, N = 115
⨁◯◯◯
MACE RD 0.00 [‐0.03, 0.03]
1 RCT, N = 112
⨁⨁◯◯
  RD 0.00 [‐0.03, 0.03]
1 RCT, N = 112
⨁⨁◯◯
    RD 0.00 [‐0.03, 0.03]
1 RCT, N = 112
⨁⨁◯◯
 
MI POR 7.02 [0.14, 354.40]
1 RCT, N = 115
⨁◯◯◯
  POR 7.02 [0.14, 354.40]
1 RCT, N = 115
⨁◯◯◯
      POR 7.02 [0.14, 354.40]
1 RCT, N = 115
⨁◯◯◯
CVA/stroke RD 0.00 [‐0.06, 0.06]
1 RCT, N = 60
⨁⨁◯◯
  RD 0.00 [‐0.06, 0.06]
1 RCT, N = 60
⨁⨁◯◯
    RD 0.00 [‐0.06, 0.06]
1 RCT, N = 60
⨁⨁◯◯
 
Hospital LOS MD ‐0.79 [‐2.30, 0.72]
4 RCTs, N = 255
⨁◯◯◯
  MD ‐0.79 [‐2.30, 0.72]
4 RCTs, N = 255
⨁◯◯◯
  MD ‐2.60 [‐4.76, ‐0.44]
1 RCT, N = 70
⨁⨁◯◯
MD ‐0.28 [‐1.59, 1.03]
3 RCTs, N = 185
⨁⨁◯◯
 

One study reporting for orthopaedic (knee) reported data for more than one collection period, and so appears in more than one subgroup for timing: Blatsoukas 2010 (postoperative only, and both).

Bolded data highlights where there was a clear intervention effect.

* neared an intervention effect (touched the line of no effect)

"Volume" refers to mean transfusion volume; "transfusions" refers to number of people receiving an allogeneic transfusion

CI: confidence interval; CVA: cerebrovascular accident; DVT: deep vein thrombosis; Hb: haemoglobin; LOS: hospital length of stay; MACE: major adverse cardiovascular events; MD: mean difference; MI: myocardial infarction; N: number of people analysed; PE: pulmonary embolism; PJI: prosthetic joint infection; POR: Peto odds ratio; PPR: per person randomised; PPT: per person transfused; RCT: randomised controlled trial; RD: risk difference; RR: risk ratio; VTE: venous thromboembolism

⨁◯◯◯ = Very low certainty; ⨁⨁◯◯ = Low certainty; ⨁⨁⨁◯ = Moderate certainty; ⨁⨁⨁⨁ = High certainty